Market revenue in 2023 | USD 263.7 million |
Market revenue in 2030 | USD 314.0 million |
Growth rate | 2.5% (CAGR from 2023 to 2030) |
Largest segment | Cannabis/marijuana |
Fastest growing segment | Cannabis/Marijuana |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Other Drug Types |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Clinical Reference Laboratory, Cordant Health Solutions, ZeOmega, Psychemedics Corp, Millennium HealthCare Inc, Mayo Clinic, Precision Diagnostics, LGC Group, Labcorp Drug Development, Legacy Medical, Drugscan, USDTL |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug of abuse testing services market will help companies and investors design strategic landscapes.
Cannabis/marijuana was the largest segment with a revenue share of 24.31% in 2023. Horizon Databook has segmented the Japan drug of abuse testing services market based on alcohol, cannabis/marijuana, cocaine, opioids, amphetamine & methamphetamine, lsd, other drug types covering the revenue growth of each sub-segment from 2018 to 2030.
According to data published by Mental Health in Family Medicine, in 2017, the lifetime usage of cannabis and stimulant drugs such as amphetamine & methamphetamine was 1.2% and 0.4%, respectively. However, in the recent past, drug use in Japan has increased.
Drugs such as amphetamines, ecstasy, and marijuana have become increasingly popular in the country. As per data published by Mental Health in Family Medicine, in 2016, around 19,453 cases were registered on drug law violations. This number includes around 15,219 cases of stimulants, 3,439 cases of cannabis, 364 cases of cocaine, and 86 cases of other drugs including MDMA.
The same source stated that the percentage of people who have committed stimulant-related crimes increased over the decade and reached 65.1% in 2016. Thus, increasing drug abuse cases and related crime in the country is anticipated to boost the demand for drug of abuse testing services.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan drug of abuse testing services market , including forecasts for subscribers. This country databook contains high-level insights into Japan drug of abuse testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account